Discover Who is Attending the Novel CNS Biomarkers Summit Europe
Discover the companies joining the Novel CNS Biomarkers Summit Europe. Featuring organisations represented by our speakers, delegates and our 2026 sponsors, this page reflects the diverse community of leaders, innovators, and decision-makers attending this year's event in London.
Attending Companies Include
AltPep
Alturos Therapeutics
Angelini Pharma
Arctic Therapeutics
Argenx
BD (Becton Dickinson)
Bial
Chiesi
Compass Pathways
Cure Parkinson’s
Dompe
Draig Therapeutics
Elkedonia
GSK
HuntX Pharma
Immunic Therapeutics
Ixico
Lundbeck
Mission Therapeutics
Neumirna Therapeutics
NRG Therapeutics
NW Pharmatech
Point6 Bio
PreTT
Progenra
PTC Therapeutics
Roche
Saniona
Servier
Teitur Trophics
Topia Life Sciences
UCB
Valaya Bio
WPD Pharmaceuticals
2026 Sponsors Include
Alamar Biosciences
Altheome
Biotrial
Fujirebio Diagnostics
Scantox
The Science Behind
Explore the Agenda
Discover the latest case studies and practical strategies shaping the future of CNS biomarker development from Lundbeck, Roche, UCB & more.
Partner With Us
Position your brand alongside Europe's leading biomarker innovators and connect with decision-makers actively seeking new technologies and partners.
Join Biopharma Experts
Exchange ideas with biomarker, translational medicine and clinical development leaders tackling the biggest challenges in neurodegenerative drug development.